Michael Ackermann - 06 Aug 2021 Form 4 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Role
Director
Signature
/s/ Leonard M. Greenstein, Attorney-in-Fact
Issuer symbol
TARS
Transactions as of
06 Aug 2021
Net transactions value
-$95,725
Form type
4
Filing time
10 Aug 2021, 16:55:05 UTC
Previous filing
06 Aug 2021
Next filing
12 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARS Common Stock Sale $78,225 -3,129 -0.25% $25.00 1,228,669 06 Aug 2021 Direct F1
transaction TARS Common Stock Sale $17,500 -700 -0.06% $25.00 1,227,969 09 Aug 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2021.